Dr. Lawrence Mendelsohn
carti logo
Principal Investigator: Dr. Lawrence Mendelsohn

EAP (RMC-6236)

Expanded Access Program to Treat Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma With Daraxonrasib

DISEASE SITE: Pancreatic Cancer
STAGE: 
Phase IV
TRIAL DESIGN: 
Industry
TRIAL TYPE: 
Investigational Product
ENROLLMENT STATUS: 
Not Enrolling

ClinicalTrials.gov ID: NCT07573215

Dr. Ryan Hall, M.D.
carti logo
Principal Investigator: Dr. Ryan Hall, M.D.

CARIS

The Caris Biorepository Research Protocol

DISEASE SITE: Solid Tumor, Hematological Malignancy
STAGE: Phase I, Phase II, Phase III, Phase IV
TRIAL DESIGN: Right on Time
TRIAL TYPE: Biospecimen
ENROLLMENT STATUS: Not Enrolling

ClinicalTrials.gov ID: NCT01499394

Dr. David Hays, M.D., FACR
carti logo
Principal Investigator: Dr. David Hays, M.D., FACR

CYBRID-02 (BSK22-2562)

Observational basket trial to collect tissue to train and validate a live tumor diagnostic platform.

DISEASE SITE: Solid Tumor
STAGE: Varies
TRIAL DESIGN: Biospecimen
TRIAL TYPE: Observational
ENROLLMENT STATUS: Not Enrolling

ClinicalTrials.gov ID: NCT05520099

Dr. David Kuperman, M.D.
carti logo
Principal Investigator: Dr. David Kuperman, M.D.

FOURLIGHT-03; C4391024

A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole in People Over 18 Years of Age With HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer who Have not Received any Prior Systemic Anticancer Treatment for Advanced/Metastatic Disease

DISEASE SITE: Breast Cancer
STAGE: Phase III
TRIAL DESIGN: Industry
TRIAL TYPE: Interventional, Investigational Product
ENROLLMENT STATUS: Not Enrolling

Clinicaltrials.gov Number: NCT06760637